Skip to main content
Clinical Trials/ACTRN12612000453886
ACTRN12612000453886
Completed
Phase 3

The effect of transfusion of fresher blood versus standard care on 28 and 90 day mortality in patients admitted to ICU.

Monash University0 sites5,000 target enrollmentApril 23, 2012

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Blood transfusion
Sponsor
Monash University
Enrollment
5000
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 23, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients hospitalised in ICU with an anticipated ICU stay of at least 24 hours, in whom the decision has been made by medical staff to transfuse at least one RBC unit.

Exclusion Criteria

  • Age younger than 18
  • A previous RBC transfusion during the current hospital admission (including transfusion in another hospital for transferred patients)
  • Diagnosis of transplantation or hematologic diseases
  • Cardiac surgery during the present hospital admission
  • Expected to die imminently (\<24hrs)
  • The treating physician believes it is not in the best interest of the patient to be randomised in this trial.
  • Known objection to the administration of human blood products
  • Participation in a competing study

Outcomes

Primary Outcomes

Not specified

Similar Trials